Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minocycline In Neurocognitive Outcomes - Sickle Cell Disease

NCT05605366 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05605366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05605366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Lead sponsor
University of Cincinnati
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
June 15, 2028
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, cognitive decline, cognitive deficit, cognitive dysfunction, cognitive impairment, neuroinflammatory response, sickle cell disease